Development of a recombinant pichinde virus-vectored vaccine against turkey arthritis reovirus and its immunological response characterization in vaccinated animals

Pawan Kumar, Tamer A. Sharafeldin, Rahul Kumar, Qinfeng Huang, Yuying Liang, Sagar M. Goyal, Robert E. Porter, Hinh Ly, Sunil K. Mor

Research output: Contribution to journalArticlepeer-review

Abstract

Vaccination may be an effective way to reduce turkey arthritis reovirus (TARV)-induced lameness in turkey flocks. However, there are currently no commercial vaccines available against TARV infection. Here, we describe the use of reverse genetics technology to generate a recombinant Pichinde virus (PICV) that expresses the Sigma C and/or Sigma B proteins of TARV as antigens. Nine recombinant PICV-based TARV vaccines were developed carrying the wild-type S1 (Sigma C) and/or S3 (Sigma B) genes from three different TARV strains. In addition, three recombinant PICVbased TARV vaccines were produced carrying codon-optimized S1 and/or S3 genes of a TARV strain. The S1 and S3 genes and antigens were found to be expressed in virus-infected cells via reverse transcriptase polymerase chain reaction (RT-PCR) and the direct fluorescent antibody (DFA) technique, respectively. Turkey poults inoculated with the recombinant PICV-based TARV vaccine expressing the bivalent TARV S1 and S3 antigens developed high anti-TARV antibody titers, indicating the immunogenicity (and safety) of this vaccine. Future in vivo challenge studies using a turkey reovirus infection model will determine the optimum dose and protective efficacy of this recombinant virus-vectored candidate vaccine.

Original languageEnglish (US)
Article number197
Pages (from-to)1-12
Number of pages12
JournalPathogens
Volume10
Issue number2
DOIs
StatePublished - Feb 2021

Bibliographical note

Publisher Copyright:
© 2021 by the author. Licensee MDPI, Basel, Switzerland.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Keywords

  • Pichinde virus
  • Recombinant vaccine
  • Sigma B
  • Sigma C
  • Subunit vaccine
  • Turkey arthritis reovirus
  • Viral vectored vaccine

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'Development of a recombinant pichinde virus-vectored vaccine against turkey arthritis reovirus and its immunological response characterization in vaccinated animals'. Together they form a unique fingerprint.

Cite this